NCT05711550

Brief Summary

In this basic research project a novel form of neurofeedback is investigated, in which in addition to the use of 1) normal frequency bands (1-35 Hertz), 2) very slow signals (low frequency; \< 0.1 Hertz) are used, which correspond more to the basic excitability of the brain. Because of the slow signal characteristics, this method is called infra-low frequency neurofeedback (ILF-NFB for short). Although this method has been successfully applied in clinical settings since the 1980s, the mechanisms underlying the effect are largely unexplored. For that purpose, a project consistiong of three studies will be conducted in order to investigate the neurophysiological effects of both signal elements on healthy participants:

  • Study 1 examines the effects of normal frequency band training alone.
  • Study 2 examines the effects of low frequency training.
  • Study 3 examines the effects of the combination of normal frequency band and low frequency training For each study, a total of 40 clean data sets are to be collected, resulting in a minimum amount of 120 participants for all three studies. All three studies investigate the effects of the neurofeedback on brain connectivity patterns by means of functional magnetic resonance imaging (fMRI), accompanied by measurements of the autonomic nervous system (ANS) and behavior.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

January 13, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 3, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2024

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

1.9 years

First QC Date

January 13, 2023

Last Update Submit

February 12, 2025

Conditions

Keywords

Neurofeedback, fMRI, resting-state

Outcome Measures

Primary Outcomes (1)

  • Functional brain connectivity

    Comparison of the Pre-Post intervention differences in resting state functional connectivity (assessed using fMRI)

    90 Minutes

Secondary Outcomes (7)

  • Heart rate Variability Pre/Post Interventions

    90 Minutes

  • Respiration frequency Pre/Post Interventions

    90 Minutes

  • Heart rate variability during interventions

    30 Minutes

  • Respiration frequency during interventions

    30 Minutes

  • Electrodermal activity during interventions

    30 Minutes

  • +2 more secondary outcomes

Other Outcomes (3)

  • Mental state pre/post intervention

    40 Minutes

  • Sleep questionnaire

    24 Hours

  • Personality questionnaires

    10 Minutes

Study Arms (3)

Healthy Subjects: Study 1

EXPERIMENTAL

This arm corresponds to study 1 (Real Neurofeedback uses only normal frequency band signals ranging from 1 to 35 Hz from the EEG-signal). All included participants participate at 2 experimental conditions (Real Neurofeedback, Sham Neurofeedback) at 2 different days in a randomized order. Both, the investigators and the participants are blinded in regard to the intervention they receive at the two experimental visits.

Device: Real NeurofeedbackDevice: Sham Neurofeedback

Healthy Subjects: Study 2

EXPERIMENTAL

This arm corresponds to study 2 (Real Neurofeedback uses only infra-low frequencies below 0.1Hz from the EEG-signal). All included participants participate at 2 experimental conditions (Real Neurofeedback, Sham Neurofeedback) at 2 different days in a randomized order. Both, the investigators and the participants are blinded in regard to the intervention they receive at the two experimental visits.

Device: Real NeurofeedbackDevice: Sham Neurofeedback

Healthy Subjects: Study 3

EXPERIMENTAL

This arm corresponds to study 3 (normal frequency band \& infra-low frequencies are used in Real Neurofeedback). All included participants participate at 2 experimental conditions (Real Neurofeedback, Sham Neurofeedback) at 2 different days in a randomized order. Both, the investigators and the participants are blinded in regard to the intervention they receive at the two experimental visits.

Device: Real NeurofeedbackDevice: Sham Neurofeedback

Interventions

Real Neurofeedback with visual and acoustic feedback presentation based on the EEG-signal from the participant (Signals used described in corresponding study arm). The NFB-signals are obtained from the T4 and P4 positions according to the 10-20 EEG placement consensus. NFB is done using the software package Cygnet (BEE Medic GmbH Technologies, Kirchberg, Switzerland) and for all participants the same neurofeedback-animation is used. NFB training duration is approx. 30min

Healthy Subjects: Study 1Healthy Subjects: Study 2Healthy Subjects: Study 3

The sham neurofeedback is performed in identical fashion using the same software, feedback, electrode placement, duration as in the real neurofeedback. Only difference is that a pre-recorded EEG-dataset will be used and the feedback signal is thus independent from the brain activity of the participant.

Healthy Subjects: Study 1Healthy Subjects: Study 2Healthy Subjects: Study 3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy
  • Written informed consent after participants' information
  • Fluent in German language (required for an adequate answering of the questionnaires)
  • No previous experience with neurofeedback treatments

You may not qualify if:

  • Alcohol, drug and analgesics consumption within the last 24 hours
  • Pre-existing neurological and/or psychiatric conditions
  • History of brain injuries
  • Alcohol and drug abuse
  • Chronic diseases that require permanent medication
  • General contraindications for MR-testings (e.g. claustrophobia, pace maker, cochlear implant, insulin pump)
  • Hypersensitivity to loud noises
  • Incapable of lying still during a longer period of time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychiatric University Hospital Zurich

Zurich, Canton of Zurich, 8032, Switzerland

Location

Study Officials

  • Philipp Stämpfli, PD PhD

    Psychiatric University Hospital, Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of MR Center

Study Record Dates

First Submitted

January 13, 2023

First Posted

February 3, 2023

Study Start

January 13, 2023

Primary Completion

December 18, 2024

Study Completion

December 18, 2024

Last Updated

February 14, 2025

Record last verified: 2025-02

Locations